Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital (SATISCHOL)

13 november 2026 uppdaterad av: University Hospital, Limoges

A Prospective Observational Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital

SATISCHOL is a prospective, monocentric observational study designed to assess pain management and quality of care in patients undergoing elective cholecystectomy at Limoges University Hospital, France.

The primary objective is to assess the proportion of patients reporting a visual analogue scale (VAS) pain score below 4 two hours after surgery, in association with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery.

Secondary objectives include assessing early postoperative pain, describing postoperative complications and intraoperative pain management techniques, and evaluating changes in patients' quality of life using the Gastrointestinal Quality of Life Index (GIQLI) and EQ-5D-5L questionnaires. Patient-reported experience will also be assessed using a study-specific questionnaire (PREMS).

A total of 70 participants are expected to be enrolled. Patients will be followed for approximately 3 to 6 weeks after surgery.

Studieöversikt

Detaljerad beskrivning

Cholecystectomy is one of the most frequently performed surgical procedures worldwide, both in elective and emergency settings. At Limoges University Hospital, 146 elective laparoscopic cholecystectomies were performed in 2024.

Cholecystectomy is indicated for the treatment of various biliary tract conditions, including biliary colic, acute or chronic cholecystitis, gallbladder polyps, gallstone pancreatitis, cholangitis and common bile duct stones.

Laparoscopic cholecystectomy, with achievement of the critical view of safety, is the standard surgical approach.

Patient-reported outcome measures (PROMs) and postoperative satisfaction have become increasingly important in the assessment of surgical outcomes and are considered key components of patient-centred care.

This study aims to assess pain management and quality of care during elective cholecystectomy at Limoges University Hospital.

Postoperative pain will be assessed using the visual analogue scale (VAS) two hours after surgery. Postoperative complications will be recorded and classified according to the Clavien-Dindo classification up to four weeks after surgery.

Intraoperative pain management techniques, including trocar-site infiltration, diaphragmatic dome infiltration with local anaesthetic and transversus abdominis plane (TAP) block, will also be documented.

Quality of life will be assessed before surgery (T0) and at postoperative follow-up (T2) using the GIQLI and EQ-5D-5L questionnaires. Patient experience will be evaluated at T2 using a study-specific PREMS questionnaire.

Data will be collected prospectively from clinical records and patient-completed questionnaires administered during the preoperative consultation and at the postoperative follow-up consultation, approximately 3 to 6 weeks after surgery.

The study is expected to contribute to the continuous improvement of pain management and quality of care for patients undergoing cholecystectomy at Limoges University Hospital.

Studietyp

Observationell

Inskrivning (Beräknad)

70

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studera Kontakt Backup

Studieorter

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Testmetod

Icke-sannolikhetsprov

Studera befolkning

Patients undergoing elective cholecystectomy, laparoscopic surgery or minimally invasive surgery.

Beskrivning

Inclusion Criteria:

  • Age 18 years or older.
  • Patients undergoing elective cholecystectomy.
  • Patients undergoing laparoscopic surgery or minimally invasive surgery, including conversion to open laparotomy when necessary.
  • Patients able to complete questionnaires independently or with the assistance of a caregiver.
  • Patients covered by a health insurance scheme.
  • Patients who have not objected to participation in the study.

Exclusion Criteria:

  • Patients undergoing emergency surgery.
  • Patients undergoing cholecystectomy when gallbladder removal is not the primary purpose of the surgical procedure.
  • Patients with a history of chronic gastrointestinal disease.
  • Patients with known gallbladder cancer.
  • Patients scheduled for open laparotomy.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiv: PROSPECTIVE

Kohorter och interventioner

Grupp / Kohort
Patients undergoing elective cholecystectomy

Adult patients undergoing elective cholecystectomy at Limoges University Hospital

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Proportion of patients with a visual analogue scale (VAS) pain
Tidsram: From two hours after surgery to four weeks postoperatively.

Proportion of patients with a visual analogue scale (VAS) pain score below 4 two hours after cholecystectomy, associated with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery.

From two hours after surgery to four weeks postoperatively.

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Proportion of patients with a VAS pain score
Tidsram: Two hours after surgery.

Proportion of patients with a VAS pain score below 4 two hours after cholecystectomy.

Two hours after surgery.
Proportion of patients experiencing early postoperative complications
Tidsram: Up to four weeks after surgery.

Proportion of patients experiencing early postoperative complications, classified according to the Clavien-Dindo classification.

Up to four weeks after surgery.
Description of intraoperative pain management techniques
Tidsram: During surgery

Assessment of intraoperative analgesic techniques used during surgery, including: local anaesthetic infiltration at trocar insertion sites, local anaesthetic infiltration of the diaphragmatic dome, transversus abdominis plane (TAP) block .

For each technique performed, the type of local anaesthetic used and the administered dose will be recorded, where applicable.

During surgery
Change in the total Gastrointestinal Quality of Life Index (GIQLI) score
Tidsram: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).

Change in the total Gastrointestinal Quality of Life Index (GIQLI) score between baseline (T0) and postoperative follow-up (T2)

Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
Change in the EQ-5D-5L visual analogue scale (VAS)
Tidsram: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).

Change in the EQ-5D-5L visual analogue scale (VAS), corresponding to the patient's self-rated health status today, between baseline (T0) and postoperative follow-up (T2).

Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
Description of patient-reported experience using the study-specific PREMS questionnaire
Tidsram: Postoperative assessment at 3 to 6 weeks (T2)

Description of patient-reported experience using the study-specific PREMS questionnaire, analysed item by item.

Postoperative assessment at 3 to 6 weeks (T2)

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Niki CHRISTOU, Professor, University Hospital, Limoges

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

13 juni 2025

Primärt slutförande (Beräknad)

13 juni 2027

Avslutad studie (Beräknad)

13 juni 2028

Studieregistreringsdatum

Först inskickad

30 oktober 2026

Först inskickad som uppfyllde QC-kriterierna

13 november 2026

Första postat (Faktisk)

17 november 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

17 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

13 november 2026

Senast verifierad

1 november 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

IPD-planbeskrivning

Individual participant data collected during this study will not be made publicly available. Data will be handled in accordance with applicable data protection regulations and institutional policies.

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera